- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
nanoTox Inc., the only company to provide complete risk assessment exclusively for nanoparticles, hopes to find its perfect match when it meets with a select group of technology firms in Tokyo, Japan, next week. The meetings, arranged in part by Japan External Trade Organization (JETRO), will take place during nano tech 2009, the world's largest annual nanotechnology exhibition and conference event on February 18-20, 2009.
"We are actively looking for a joint venture partner in the Pacific region," said Greg King, nanoTox Chief Operating Officer and former director of corporate treasury with Mitsubishi Caterpillar Forklift, a subsidiary of Mitsubishi Heavy Industries headquartered in Tokyo. "This event will allow us to meet with many of the region's most capable firms with understanding of and mutual interests in the nanotech arena, especially regarding nanotoxicology risk assessment. Japan is an important center for nano-technology development and use."
Companies and organizations from all over the world will showcase their cutting-edge products, services and technologies during nano tech 2009. Last year's conference attracted 49,365 visitors and 522 exhibitors.
"This year will see dramatic changes in regulatory policy affecting nanotechnology," said King. "As companies with nanoparticles in their products prepare for market, they will require much more analysis of the risks those particles may pose to the environment and public health. We are looking for a partner that will allow nanoTox to further assist those companies in rapid assessment of their products so that we can help them mitigate or manage risks appropriately and shorten their time to market."
About nanoTox Inc.
Located in Austin, Texas, nanoTox is the only company to provide complete assessment exclusively for nanoparticles. Using state of the art toxicologic procedures designed specifically for nanomaterials, nanoTox evaluates the safety of its clients’ nanoproducts and offers strategies for managing, reducing or eliminating risk to meet state and federal safety guidelines and shorten time to market. Because nanoTox uses methodologies that are performed under recognized international data quality standards (GLP, ISO, etc.) in its laboratories, the results and associated assessments are suitable for use to support investment, development and regulatory decisions, product registrations, litigation and for acceptance by the insurance industry.
nanoTox ensures complete client confidentiality for all of its clients, which include companies or entities that require government approval to market their nanoproducts, venture capital firms that invest in nanoproduct companies, law firms engaged by such companies and insurance companies considering insuring such companies from liability.
nanoTox is headquartered in Austin, Texas, with offices in Maastricht, Netherlands.
About JETRO and nano tech 2009
The Japan External Trade Organization (JETRO) is a government-related organization that works to promote mutual trade and investment between Japan and the rest of the world. February 18-20, 2009, JETRO will host "BIZMATCH @ nano tech 2009" a company presentation and business matching event, during nano tech 2009, the world's largest nanotechnology event. Held in association with the Nanotechnology Business Creation Initiative, BIZMATCH @ nano tech 2009 connects Japanese and foreign firms in nanotechnology and related high-tech fields.
For more information on JETRO, visit www.jetro.go.jp/.
For information on nano tech 2009, visit www.nanotechexpo.jp/en/.
For more information, please click here
Laura P. Wright
CameronWeeks Public Relations
Copyright © nanoToxIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
BESSTECH Announces $250K Investment from Eastern New York Angels : Funding will accelerate commercialization of BESSTECH’s innovative lithium-ion battery electrode technology and enable hiring of key personnel May 13th, 2015
Harris & Harris Group Sponsors NYC American Heart Association's Health Sciences Innovation Investment Forum: Co-founder of Harris & Harris Group Portfolio Company TARA Biosystems to Speak About the Value of Tissue Engineering Technology April 21st, 2015
Long Island Capital Alliance Announces Participants for Brookhaven National Laboratory Technology Transfer Capital Forum on May 8: Keynote Speaker Dr. Doon Gibbs, Director of Brookhaven National Laboratory April 16th, 2015
Cotton fibres instead of carbon nanotubes May 9th, 2015